Maxim Group set a $8.00 price objective on BioLife Solutions (NASDAQ:BLFS) in a research note released on Thursday morning. The brokerage currently has a buy rating on the medical equipment provider’s stock.
BioLife Solutions (NASDAQ BLFS) traded up $0.04 during trading on Thursday, hitting $5.89. 103,300 shares of the stock traded hands, compared to its average volume of 82,200. BioLife Solutions has a twelve month low of $1.62 and a twelve month high of $7.53. The stock has a market cap of $81.51, a PE ratio of -14.02 and a beta of 0.27.
BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative net margin of 52.10% and a negative return on equity of 49.92%. The business had revenue of $2.96 million during the quarter, compared to analysts’ expectations of $2.60 million. analysts forecast that BioLife Solutions will post -0.23 earnings per share for the current year.
Several institutional investors have recently bought and sold shares of the company. Essex Investment Management Co. LLC purchased a new stake in shares of BioLife Solutions in the 3rd quarter valued at approximately $484,000. EAM Investors LLC purchased a new position in shares of BioLife Solutions during the 3rd quarter worth approximately $555,000. Finally, Granite Investment Partners LLC purchased a new position in shares of BioLife Solutions during the 3rd quarter worth approximately $1,205,000. 9.41% of the stock is owned by institutional investors and hedge funds.
BioLife Solutions Company Profile
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.